| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Exec. VP And CLO | Exec. VP And CLO
1 company
Boulding Mark Elliott is an Exec. VP And CLO at PTC THERAPEUTICS, INC.. Recent SEC Form 4 filings include 0 buys and 39 sells.
Estimated insider holdings value: $8.7M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Feb 1, 2021 | PTCT Ptc Therapeutics, Inc. | Exec. VP And CLO | Sell | 778 | $56.96 | $44,311.77 | -1.6% | |
| Jan 5, 2021 | PTCT Ptc Therapeutics, Inc. | Exec. VP And CLO | Sell | 772 | $62.37 | $48,149.64 | -1.9% | |
| Jul 7, 2020 | PTCT Ptc Therapeutics, Inc. | Exec. VP And CLO | Sale+OE | 30,625 | $55.12 | $1,688,036.59 | -3.5% | |
| Jul 5, 2019 | PTCT Ptc Therapeutics, Inc. | Exec. VP And CLO | Sale+OE | 15,312 | $44.74 | $685,097.12 | -6.0% | |
| Jul 1, 2019 | PTCT Ptc Therapeutics, Inc. | Exec. VP And CLO | Sale+OE | 181,667 | $45.00 | $8,175,015.00 | -35.9% |